ENTRY       D12458                      Drug
NAME        Ozekibart (USAN)
FORMULA     C4730H7216N1268O1428S32
EXACT_MASS  105652.2076
MOL_WEIGHT  105717.6248
SEQUENCE    EVQLLESGGG EVQPGGSLRL SCAASGLTFP NYGMGWFRQA PGKEREFVSA IYWSGGTVYY
            AESVKGRFTI SRDNAKNTLY LQMSSLRAED TAVYYCAVTI RGAATQTWKY DYWGQGTLVT
            VKPGGSGGSE VQLLESGGGE VQPGGSLRLS CAASGLTFPN YGMGWFRQAP GKEREFVSAI
            YWSGGTVYYA ESVKGRFTIS RDNAKNTLYL QMSSLRAEDT AVYYCAVTIR GAATQTWKYD
            YWGQGTLVTV KPGGGGDKTH TCPPCPAPGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS
            HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA
            LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE LTKNQVSLTC LVKGFYPSDI AVEWESNGQP
            ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPGK
            (Disulfide bridge: 22-96, 151-225, 262-262', 265-265', 294-354, 400-458, 22'-96', 151'-225', 294'-354', 400'-458')
  TYPE      Peptide
EFFICACY    Antineoplastic, Death receptor 5 agonit
  TYPE      Monoclonal antibody
TARGET      TNFRSF10B (TRAILR2, CD262) [HSA:8795] [KO:K04722]
  PATHWAY   hsa04060(8795)  Cytokine-cytokine receptor interaction
            hsa04115(8795)  p53 signaling pathway
            hsa04210(8795)  Apoptosis
            hsa04217(8795)  Necroptosis
            hsa04650(8795)  Natural killer cell mediated cytotoxicity
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF10B (TRAILR2, CD262)
                 D12458  Ozekibart (USAN)
DBLINKS     CAS: 2539847-03-3
///
